https://www.selleckchem.com/TGF-beta.html
Recent data support a role for endoscopic radiofrequency ablation (RFA) in unresectable cholangiocarcinoma by improving stent patency and overall survival. We describe 3 patients with inoperable cholangiocarcinoma with jaundice and cholestasis who were recommended palliative chemotherapy. They underwent endoscopic retrograde cholangiopancreatography with single-operator cholangioscope and intraductal RFA. The procedures were performed without adverse events in all patients, with clinical and analytical improvement 1 month later. RFA is a promis
Aimer
Commentaire
Partagez
